Querying the glioblastoma database of The Cancer Genome Atlas (TCGA) for the mRNA abundances of putative methadone targets indicates undetectably low OPRM1 (μ-opioid receptor) mRNA abundance in the majority of glioblastoma specimens (Figure 1A,B, first box plot). This evidence concerns the gene OPRM1 and glioblastoma.